---
figid: PMC9539685__fgene-13-1006936-g002
figtitle: Research progress on the relationship between the TOR signaling pathway
  regulator, epigenetics, and tumor development
organisms:
- NA
pmcid: PMC9539685
filename: fgene-13-1006936-g002.jpg
figlink: /pmc/articles/PMC9539685/figure/F2/
number: F2
caption: The role of the TIPRL/PP2A axis in cancer development. PP2A is comprised
  of a scaffold, a regulatory, and a catalytic (C or PP2Ac) subunit, a variable B
  subunit that comes from four major families, including B, B′, B″, and B‴. PP2A holoenzyme,
  as a tumor suppressor, can inhibit MYC, Cyclin-dependent kinase 1 (Cdk1), B-cell
  lymphoma 2 (Bcl-2), Extracellular signal-regulated kinase (ERK), wnt/β-catenin,
  and eukaryotic translation initiation factor 4E (eIF4E). In addition to inhibition
  of PP2A, TIPRL can also participate in TRAIL-induced apoptosis and subsequent phosphorylation
  of MAP kinase 7 (MKK-7) and c-Jun N-terminal kinase (JNK), resulting in cancer cell
  apoptosis.
papertitle: Research progress on the relationship between the TOR signaling pathway
  regulator, epigenetics, and tumor development.
reftext: Jiaen Sun, et al. Front Genet. 2022;13:1006936.
year: '2022'
doi: 10.3389/fgene.2022.1006936
journal_title: Frontiers in Genetics
journal_nlm_ta: Front Genet
publisher_name: Frontiers Media S.A.
keywords: TOR signaling pathway regulator | protein phosphatase | cancer | epigenetic
  | metabolism
automl_pathway: 0.9468899
figid_alias: PMC9539685__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9539685__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9539685__fgene-13-1006936-g002.html
  '@type': Dataset
  description: The role of the TIPRL/PP2A axis in cancer development. PP2A is comprised
    of a scaffold, a regulatory, and a catalytic (C or PP2Ac) subunit, a variable
    B subunit that comes from four major families, including B, B′, B″, and B‴. PP2A
    holoenzyme, as a tumor suppressor, can inhibit MYC, Cyclin-dependent kinase 1
    (Cdk1), B-cell lymphoma 2 (Bcl-2), Extracellular signal-regulated kinase (ERK),
    wnt/β-catenin, and eukaryotic translation initiation factor 4E (eIF4E). In addition
    to inhibition of PP2A, TIPRL can also participate in TRAIL-induced apoptosis and
    subsequent phosphorylation of MAP kinase 7 (MKK-7) and c-Jun N-terminal kinase
    (JNK), resulting in cancer cell apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDZ-GEF
  - garz
  - RhoGEF64C
  - pbl
  - Pdfr
  - Rheb
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Myb
  - Pi3K21B
  - Taf5
  - S6k
  - tor
  - Tor
  - Egfr
  - Thor
  - Pten
  - Tsc1
  - gig
  - Tsc
  - Pdk1
  - Akt
  - mts
  - Prosalpha4
  - alphaTub67C
  - nAChRalpha4
  - ARHGEF2
  - SLC2A4RG
  - OPN1MW
  - OPN1MW2
  - OPN1MW3
  - RHEB
  - RHEBP1
  - CUX1
  - SART3
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - RPS6KB1
  - RORC
  - EIF4EBP1
  - PTEN
  - TSC1
  - CCL26
  - TSC2
  - SLC12A3
  - TESC
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - PPP2CA
  - IGBP1
  - TIPRL
---
